600222 Henan Taloph Pharmaceutical StockWatchlist
About Henan Taloph Pharmaceutical Stock Company
The company was founded in 1993, and in 1999, Tailong Pharmaceutical's shares were solemnly listed on the Shanghai Stock Exchange, becoming the first listed company in the pharmaceutical industry in Henan Province. After more than 20 years of development, Tailong Pharmaceutical has indirectly participated in shares and controlled more than a dozen subsidiaries (branches) of companies. The fields covered include pharmaceutical manufacturing, drug research and development, capital operation, etc., and the main economic indicators rank among the top in the pharmaceutical industry in Henan Province. The company's main business is pharmaceutical manufacturing and drug research and development services. Specifically, it includes the four business segments of pharmaceutical preparations, traditional Chinese medicine tablets, pharmaceutical research and development services, and distribution of pharmaceuticals and medicinal materials. The company's pharmaceutical formulation business mainly focuses on oral traditional Chinese medicine formulations. The treatment areas cover respiratory system, cardiovascular system, digestive system, nervous system and gynecological diseases. The main products include Shuanghuanglian oral liquid series, Shuangjin conjugate, pediatric heat clearing and cough relief oral liquid, pediatric antipyretic oral liquid, pediatric compound chicken internal chewable tablets, salvia, salvia, compound Yimu oral liquid, huasperine tablets, etc. Among them, Shuanghuanglian Oral Liquid (concentrated type), Shuanghuanglian Oral Liquid (children type), Shuangjin Conjugate, and Pediatric Compound Chicken Neijin Chewable Tablets are the company's exclusive products. Corporate honors: The Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce awarded the company the honor of “Anti-epidemic, Charity, and Caring”, a high-tech enterprise in Henan Province, “National High-tech Industrialization Demonstration Project”, “Outstanding Enterprise in Zhengzhou”, selected as “2022 Top 100 Chinese Pharmaceutical Enterprises” by the China Traditional Chinese Medicine Association, and “2022 Top 100 Proprietary Chinese Medicine Enterprises” by the China Association of Traditional Chinese Medicine. It was rated by the Henan Provincial People's Government as a “Key Leading Enterprise in Agricultural Industrialization in Henan Province (2022-2024)”, “Enterprise Responsible for Anti-epidemic Insurance and Supply”, “High-tech Enterprise Responsible for Anti-epidemic Insurance and Supply”, “Zhengzhou High-tech Enterprise” 2022 “Top 20 Science and Technology Innovation Enterprises”, etc.
Tailong Pharmaceutical (600222.SH): No antibiotics
Gelonghui November 28丨Tailong Pharmaceutical (600222.SH) stated on the investor interactive platform that the company has no antibiotics yet.
Tailong Pharmaceutical (600222.SH): Salvia salvia, a proprietary Chinese medicine product, has the effect of activating blood circulation and nourishing the heart
Gelonghui, November 22|Tailong Pharmaceutical (600222.SH) stated on the investor interactive platform that the company's proprietary Chinese medicine product salvia salvia oral liquid has the effects of activating blood circulation and nourishing the heart. Viburnum can nourish the heart, and nourish the stomach, and nourish the heart, all of which are drugs for the cardiovascular and cerebrovascular system.
Tailong Pharmaceutical (600222.SH): The controlling shareholder has not yet launched other major pharmaceutical and health management businesses
Gelonghui November 22|Tailong Pharmaceutical (600222.SH) stated on the investor interactive platform that the company's controlling shareholder has not yet carried out any other major pharmaceutical health business.